Search

everythinglearnresearchcommunity

for

Search:↓

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Cryptotanshinone may help treat postmenopausal osteoporosis and protect kidneys.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

The document's conclusion cannot be provided because the document is not available or cannot be read.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Nocturnal calcium infusions improved a boy's severe rickets without causing hair loss.

Drugs like PDEI may help hair disorders like AGA.

Scientists found new nonsteroidal compounds that can act like natural male hormones and might help treat male fertility and hormone issues.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Diet can prevent bone issues but not hair loss in mice lacking vitamin D receptors.

New vitamin D3 forms need the vitamin D receptor to reduce fibrosis in human cells.

Vitamin D receptor binds similarly to natural and synthetic ligands, affecting gene regulation.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.